Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Annexin V-APC/7-AAD Apoptosis Kit Guide
2026-08-27
The Annexin V-APC/7-AAD Apoptosis Kit is an apoptosis detection kit that combines phosphatidylserine recognition with membrane-integrity staining. Its dual-parameter readout supports rapid apoptosis and necrosis detection by flow cytometry or fluorescence microscopy.
-
N1-Methylpseudouridine for mRNA Translation
2026-08-27
N1-Methylpseudouridine is a modified nucleoside for mRNA translation enhancement and protein-expression studies. A cited preprint found that combining this modification with GC3 codon optimization produced approximately 1,000-fold greater luciferase potency than wild-type, unmodified mRNA, while product information reports high solvent solubility and research-use validation.
-
β-Elemene: AMPK, Apoptosis & Research Use
2026-08-26
β-Elemene, also called Levo-β-elemene, is a natural sesquiterpene used in apoptosis, inflammation, neuroprotection, and metabolic research. A 2025 3T3-L1 study found that β-Elemene reduced MDI-induced adipogenesis, improved glucose consumption in an insulin-resistance model, and restored AMPK pathway activity.
-
Flexible Phage Surfaces for Rare CTC Subtyping
2026-08-26
The reference study shows that mechanically flexible M13 bacteriophages can improve circulating tumor cell capture while suppressing nonspecific white blood cell adsorption. By combining aptamer-functionalized phage nanofibers, magnetic isolation, and immunostaining, the authors achieved strong discrimination between breast cancer patients and healthy donors and supported cancer subtype assignment.
-
TLS, TRAF2 Competition, and B-Cell Activation in ESCC
2026-08-25
The 2025 Cancer Gene Therapy study links tertiary lymphoid structures with favorable survival in treatment-naïve esophageal squamous cell carcinoma and identifies IRF4-positive B-cell activation as a mechanistic feature. Its central finding is that CD40 and STING compete for TRAF2, coordinating non-canonical NF-κB signaling, STING modification, and IRF4 expression.
-
Latent HIV-1, Telomeres, and DNA Damage Vulnerability
2026-08-25
The 2018 study by Piekna-Przybylska and Maggirwar shows that HIV-1 infection and latency are associated with telomere elongation in memory CD4+ T cells, while simultaneously increasing sensitivity to telomere-targeting agents. Its findings connect HIV reservoir persistence with altered DNA damage response capacity and suggest a mechanistic basis for selectively stressing infected cells.
-
AO/PI and the Translational Logic of Kidney Injury
2026-08-24
How AO/PI Staining Solution connects membrane integrity, mechanistic nephropathy research, and more reproducible translational decisions in diabetic kidney disease models.
-
Bedaquiline in Viability and TB Assays
2026-08-23
This scenario-based guide explains how Bedaquiline (SKU B3492) can support reproducible tuberculosis and cancer-cell experiments while avoiding metabolic-assay misinterpretation. It connects formulation, exposure design, orthogonal readouts, and host-directed tuberculosis research for practical laboratory decision-making.
-
NAT1–ENO1–Lactate Axis in Colorectal Cancer
2026-08-22
A 2026 MedComm study identifies NAT1 as a metabolic–immune regulator that restrains ENO1 activity, lactate production, and TRAF6-dependent PD-L1 stabilization in colorectal cancer. Its integrated database, multi-omics, patient, cellular, and mouse-model evidence provides a mechanistic rationale for testing lactate-pathway perturbation alongside immune checkpoint blockade, while remaining preclinical.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-08-22
Saito and colleagues developed a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids could be propagated, cryopreserved, and differentiated into intestinal epithelial cells with enterocyte-associated metabolic and transporter activities, creating a human-relevant platform for pharmacokinetic research.
-
PYR-41: E1 Inhibition for Ubiquitination Research
2026-08-21
PYR-41 provides an upstream chemical entry point for studying ubiquitin-dependent protein turnover, IκBα stability, inflammatory signaling, and cell survival. This workflow-focused guide explains how to select concentrations, verify E1 engagement, connect results to NF-κB biology, and avoid misinterpreting off-target effects.
-
Birinapant (TL32711) in Apoptosis Workflows
2026-08-20
Birinapant (TL32711) converts IAP biology into a practical sensitization strategy for apoptosis, TNF signaling, and TRAIL-based cancer assays. This guide connects its mechanism with MDM1–p53 chemoradiotherapy findings and provides workflow parameters, controls, and troubleshooting guidance for translational research.
-
Ziprasidone Augmentation in Anxious Depression
2026-08-20
This post-hoc analysis examined whether baseline anxious depression moderated the effects of ziprasidone added to escitalopram in patients with major depressive disorder. Depression outcomes did not differ significantly by anxiety subgroup, while the numerical anxiety benefit was not clinically meaningful, underscoring the need to distinguish symptom-domain effects in antidepressant research.
-
M344 Histone Deacetylase Inhibitor Workflows
2026-08-19
M344 combines cell permeability with potent HDAC inhibition for concentration-response studies, cell differentiation induction, cancer phenotyping, radiation-sensitization experiments, and HIV-1 latency research. This practical guide emphasizes assay controls, soluble stock preparation, orthogonal readouts, and toxicity-aware optimization.
-
IBDV VP3 Disrupts IRF7 Antiviral Signaling
2026-08-19
A 2025 study identifies the infectious bursal disease virus VP3 protein as a mediator of IRF7 suppression and proteasome-associated IRF7 degradation in chicken cells. The findings connect a viral structural protein with disruption of type I interferon signaling and provide a framework for testing ubiquitination-dependent mechanisms of viral immune evasion.